Intrexon Corp. (XON)

Company Description

Intrexon Corporation, founded in 1998, is a biotechnology company focused on collaborating with companies in Health, Food, Energy, and Environment to create biologically based products that improve quality of life and the health of the planet. At present rates of global industrialization and population growth, food and energy supplies and environmental and healthcare resources are becoming scarcer. We believe Intrexon’s leading Better DNA™ approach to synthetic biology has the potential to provide new, more effective and sustainable solutions to address these challenges.

With a suite of proprietary and complementary technologies, Intrexon applies engineering to biological systems to enable DNA-based control over the function and output of living cells. Working with key collaborators, Intrexon seeks to develop high value applications that can bring better medicines to more people, alleviate shortages of essential nutrients, develop renewable fuels and other resources, and protect the environment..

0374 Seneca Meadows Parkway
Germantown, Maryland 20876
United States



Get BioInvest's perspective on Intrexon's CEO

Latest Company News

Intrexon to Announce Fourth Quarter and Full Year 2016 Financial Results on ... Yahoo Finance - 25 minutes ago 22, 2017 /PRNewswire/ -- Intrexon Corporation (XON), a leader in the engineering and industrialization of biology to improve the quality of life and health of the planet, today announced it will release fourth quarter and full year 2016 financial ... [...]
Wed, Feb 22, 2017 1:03:00 PM, Continue reading at the source
Stock Returns: Opko Health Inc (NASDAQ:OPK) is Beating Intrexon Corporation ... CML News - Feb 21, 2017 This is a snapshot to compare the stock returns for Opko Health Inc (NASDAQ:OPK) versus Intrexon Corporation (NYSE:XON) . The stock return points we compare look at the last three-months, six-months and twelve-months. Yearly Sales Estimates Of Intrexon Corporation (NYSE:XON) At $61 - Equities Focus The Northland Securities Begins Coverage on Intrexon Corporation (XON) - DailyQuint [...]
Tue, Feb 21, 2017 12:33:00 PM, Continue reading at the source
Did a Case of Buyer's Remorse Send Intrexon Corporation Down 13% in January? Motley Fool - Feb 6, 2017 Shares of Intrexon (NYSE: XON), a life sciences company focused on the development of proprietary technologies designed to regulate genes with the purpose of treating serious diseases, fell 13% during the month of January, according to data from S&P ... Intrexon Corporation (XON) Given a $42.00 Price Target by JMP Securities Analysts - BNB Daily (blog) Analyst's Proposition on Intrexon Corporation (XON), Owens-Illinois, Inc. (OI) - The USA Commerce [...]
Mon, Feb 06, 2017 4:41:00 PM, Continue reading at the source
Intrexon Corp (NYSE:XON) Stock Worth Watching Live Trading News - Feb 3, 2017 During the past 10 bars, there have been 3 white candles and 7 black candles for a net of 4 black candles. During the past 50 bars, there have been 23 white candles and 27 black candles for a net of 4 black candles. [...]
Fri, Feb 03, 2017 6:56:00 AM, Continue reading at the source
Bill Miller is bullish about this Maryland biotech that makes non-browning apples Baltimore Business Journal - Feb 2, 2017 Intrexon will be releasing its "Arctic Apple" and genetically modified salmon this year, Miller said. He met with the company's billionaire CEO Randal J. Kirk last week, who told him about the Intrexon's latest invention - a genetically modified ... [...]
Thu, Feb 02, 2017 6:12:00 PM, Continue reading at the source
Massive Carl Icahn Takeover Trade Highlights Insider Buying: Federal Mogul ... 24/7 Wall St. - Jan 29, 2017 Randall Kirk, who is the board chair and the chief executive officer of Intrexon Corp. (NYSE: XON), bought a total of 2,421,073 shares of its stock. [...]
Sun, Jan 29, 2017 3:11:00 PM, Continue reading at the source
Intrexon To Buy GenVec For $7 a Share (XON, GNVC) Investopedia - Jan 25, 2017 Maryland-based Intrexon Corp. (XON) agreed to acquire fellow Maryland gene-delivery platform developer GenVec Inc. (GNVC) in an all-stock deal for $7 a share. Hot Biotech Stocks To Watch Right Now: Sage Therapeutics (SAGE), GenVec (GNVC) - The Independent Republic [...]
Wed, Jan 25, 2017 3:11:00 PM, Continue reading at the source
Intrexon Corporation (XON) Moves Lower on Volume Spike for January 24 - Jan 24, 2017 Intrexon Corporation (XON) traded on unusually high volume on Jan. 24, as the stock lost 1.99% to close at $21.65. On the day, Intrexon Corporation saw 2.11 million shares trade hands on 13,741 trades. Considering that the stock averages only a daily ... Intrexon Corp. (XON) Given Average Recommendation of “Buy” by Brokerages - Sports Perspectives Intrexon Corporation (NYSE:XON) Stock Technicals Hit Extreme Weakness - CML News [...]
Tue, Jan 24, 2017 10:30:00 PM, Continue reading at the source
Intrexon to acquire fellow Md. biotech Washington Business Journal - Jan 24, 2017 Germantown-based Intrexon Corp. is swallowing up its fellow Montgomery County biotech, GenVec Inc., a small Gaithersburg gene therapy company that has been struggling to grow since its lead cancer drug candidate failed in late-stage trials in 2010. Intrexon to acquire GenVec in all-stock deal - Seeking Alpha [...]
Tue, Jan 24, 2017 5:35:00 PM, Continue reading at the source
Better Buy: Intrexon Corporation vs. bluebird bio Motley Fool - Dec 13, 2016 That's the message engineered biology conglomerate Intrexon (NYSE:XON) is trying to send out to investors. Sure, it has a formidable lineup of clinical trials and biopharma partners, but it's also leveraging the power of biology to develop next ... [...]
Tue, Dec 13, 2016 4:30:00 PM, Continue reading at the source